Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis
- PMID: 33069725
- PMCID: PMC7557272
- DOI: 10.1016/j.chest.2020.10.014
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented burden on the delivery of intensive care services worldwide.
Research question: What is the global point estimate of deaths and risk factors for patients who are admitted to ICUs with severe COVID-19?
Study design and methods: In this systematic review and meta-analysis Medline, Embase, and the Cochrane library were searched up to August 1, 2020. Pooled prevalence of participant characteristics, clinical features, and outcome data was calculated with the use of random effects models. Subgroup analyses were based on geographic distribution, study type, quality assessment, sample size, end date, and patient disposition. Studies that reported in-hospital mortality rate of adult patients (age >18 years) with confirmed COVID-19 admitted to an ICU met study eligibility criteria. Critical evaluation was performed with the Newcastle Ottawa Scale for nonrandomized studies.
Results: Forty-five studies with 16,561 patients from 17 countries across four continents were included. Patients with COVID-19 who were admitted to ICUs had a mean age of 62.6 years (95% CI, 60.4-64.7). Common comorbidities included hypertension (49.5%; 95% CI, 44.9-54.0) and diabetes mellitus (26.6%; 95% CI, 22.7-30.8). More than three-quarters of cases experienced the development of ARDS (76.1%; 95% CI, 65.7-85.2). Invasive mechanical ventilation was required in 67.7% (95% CI, 59.1-75.7) of case, vasopressor support in 65.9% (95% CI, 52.4-78.4) of cases, renal replacement therapy in 16.9% (95% CI, 12.1-22.2) of cases, and extracorporeal membrane oxygenation in 6.4% (95% CI, 4.1-9.1) of cases. The duration of ICU and hospital admission was 10.8 days (95% CI, 9.3-18.4) and 19.1 days (95% CI, 16.3-21.9), respectively, with in-hospital mortality rate of 28.1% (95% CI, 23.4-33.0; I2 = 96%). No significant subgroup effect was observed.
Interpretation: Critically ill patients with COVID-19 who are admitted to the ICU require substantial organ support and prolonged ICU and hospital level care. The pooled estimate of global death from severe COVID-19 is <1 in 3.
Keywords: SARS-CoV-2; coronavirus; critical illness; intensive care; respiratory medicine.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review.Clin Microbiol Infect. 2021 Jan;27(1):47-54. doi: 10.1016/j.cmi.2020.10.017. Epub 2020 Oct 23. Clin Microbiol Infect. 2021. PMID: 33190794 Free PMC article.
-
Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.Turk J Med Sci. 2021 Apr 30;51(2):440-447. doi: 10.3906/sag-2005-57. Turk J Med Sci. 2021. PMID: 33185365 Free PMC article.
-
[Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center].Anaesthesist. 2021 Jul;70(7):573-581. doi: 10.1007/s00101-020-00906-3. Epub 2020 Dec 28. Anaesthesist. 2021. PMID: 33369696 Free PMC article. German.
-
Acute Kidney Injury, Renal Replacement Therapy, and Extracorporeal Membrane Oxygenation Treatment During the COVID-19 Pandemic: Single-Center Experience.Medicina (Kaunas). 2025 Jan 28;61(2):237. doi: 10.3390/medicina61020237. Medicina (Kaunas). 2025. PMID: 40005354 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
Cited by
-
The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients.Biomedicines. 2024 Jul 20;12(7):1618. doi: 10.3390/biomedicines12071618. Biomedicines. 2024. PMID: 39062191 Free PMC article.
-
Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control.J Hosp Infect. 2022 Jan;119:149-154. doi: 10.1016/j.jhin.2021.09.020. Epub 2021 Oct 8. J Hosp Infect. 2022. PMID: 34627934 Free PMC article.
-
Flexibility during the COVID-19 Pandemic Response: Healthcare Facility Assessment Tools for Resilient Evaluation.Int J Environ Res Public Health. 2021 Oct 31;18(21):11478. doi: 10.3390/ijerph182111478. Int J Environ Res Public Health. 2021. PMID: 34769993 Free PMC article. Review.
-
Glycated haemoglobin levels among 3295 hospitalized COVID-19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all-cause mortality.Diabetes Obes Metab. 2022 Mar;24(3):499-510. doi: 10.1111/dom.14604. Epub 2021 Dec 5. Diabetes Obes Metab. 2022. PMID: 34779086 Free PMC article.
-
Clinical and organizational framework of repurposing pediatric intensive care unit to adult critical care in a resource-limited setting: Lessons from the response of an urban general hospital to the COVID-19 pandemic.J Crit Care. 2022 Apr;68:59-65. doi: 10.1016/j.jcrc.2021.12.004. Epub 2021 Dec 15. J Crit Care. 2022. PMID: 34922313 Free PMC article.
References
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;7(13):1239–1242. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous